Universal BRCA testing and family outreach for women with triple negative breast cancer

被引:5
|
作者
Emborgo, T. [1 ]
Muse, K. I. [1 ]
Bednar, E. [1 ]
Oakley, H. D. [1 ]
Litton, J. [1 ]
Lu, K. H. [1 ]
Arun, B. K. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
10.1158/1538-7445.SABCS15-P2-09-08
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2-09-08
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Prospective Evaluation of Universal BRCA Testing for Women With Triple-Negative Breast Cancer
    Emborgo, Trisha S.
    Saporito, Donika
    Muse, Kimberly, I
    Barrera, Angelica M. Gutierrez
    Litton, Jennifer K.
    Lu, Karen H.
    Arun, Banu K.
    [J]. JNCI CANCER SPECTRUM, 2020, 4 (02)
  • [2] BRCA1 testing for triple-negative breast cancer
    Bennet, Neil
    [J]. LANCET ONCOLOGY, 2012, 13 (04): : E143 - E143
  • [3] BRCA Testing and It's Influence on The Surgical Management Triple Negative Breast Cancer
    Greene, A.
    Hegarty, A.
    O'Leary, P.
    Hill, A. D. K.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S326 - S326
  • [5] Impact of BRCA Mutation Status on Survival of Women With Triple-negative Breast Cancer
    Yadav, Siddhartha
    Ladkany, Rand
    Yadav, Dhiraj
    Alhalabi, Omar
    Khaddam, Sinan
    Isaac, Daniel
    Cardenas, Paola Yumpo
    Zakalik, Dana
    [J]. CLINICAL BREAST CANCER, 2018, 18 (05) : E1229 - E1235
  • [6] Prevalence of BRCA1 and BRCA2 mutations in Jewish women with triple negative breast cancer
    Comen, E. A.
    Davids, M.
    Kirchhoff, T.
    Balistreri, L.
    Hansen, J.
    Kosarin, K.
    Offit, K.
    Robson, M. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] BRCA mutations among triple negative breast cancer without family history of breast and ovarian cancer: The Modena family cancer clinic experience
    Molinaro, E.
    Venturelli, M.
    Toss, A.
    Piombino, C.
    Barbieri, E.
    Marcheselli, L.
    Marchi, I.
    Tagliafico, E.
    Cascinu, S.
    Cortesi, L.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [8] BRCA testing and outcomes in women with breast cancer
    David D. Stenehjem
    Claire Telford
    Sudhir K. Unni
    Hillevi Bauer
    Amy Sainski
    Rishi Deka
    Marisa B. Schauerhamer
    Xiangyang Ye
    Casey R. Tak
    Junjie Ma
    Tapashi B. Dalvi
    Lia Gutierrez
    James A. Kaye
    Jerzy E. Tyczynski
    Diana I. Brixner
    Joseph E. Biskupiak
    [J]. Breast Cancer Research and Treatment, 2021, 186 : 839 - 850
  • [9] BRCA testing and outcomes in women with breast cancer
    Stenehjem, David D.
    Telford, Claire
    Unni, Sudhir K.
    Bauer, Hillevi
    Sainski, Amy
    Deka, Rishi
    Schauerhamer, Marisa B.
    Ye, Xiangyang
    Tak, Casey R.
    Ma, Junjie
    Dalvi, Tapashi B.
    Gutierrez, Lia
    Kaye, James A.
    Tyczynski, Jerzy E.
    Brixner, Diana I.
    Biskupiak, Joseph E.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (03) : 839 - 850
  • [10] Impact of germline BRCA mutation status on survival in women with metastatic triple negative breast cancer
    Larson, K.
    Wang, Y. Y.
    Finke, K.
    O'Dea, A. P.
    Khan, Q.
    Nye, L.
    Heldstab, J.
    Godwin, A. K.
    Kimler, B. F.
    Sharma, P.
    [J]. CANCER RESEARCH, 2019, 79 (04)